
MOSCOW: Russia is expected to register a second potential vaccine against COVID-19 on Oct. 15, the vaccine's developer said on Friday.
The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last month.
The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last month.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.